BillionToOne, Inc. Class A Common Stock (BLLN.US)
10-Year StudyBLLN.US · Healthcare · Common Stock
About BillionToOne, Inc. Class A Common Stock (BLLN.US)
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection....
Fundamental Snapshot
BillionToOne, Inc. Class A Common Stock (BLLN.US) reports a gross margin of 71.3% and an operating margin of 5.0%. Quarterly revenue changed +64.4% year-over-year. Financially, its return on equity is 10.7%, current ratio stands at 11.69x, debt-to-equity ratio is 0.27x.
Executive Summary: BillionToOne, Inc. Class A Common Stock has compounded at -12.8% annually over the last 10 years, with a maximum drawdown of 42.3% and an annualized volatility of 221.8%.
History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.
10-Year Growth of $10,000
View full price history data
| Date | Value |
|---|---|
| 2025-11-01 | $10,000 |
| 2025-12-01 | $6,287 |
| 2026-01-01 | $6,338 |
| 2026-02-01 | $5,863 |
| 2026-03-01 | $6,064 |
| 2026-04-01 | $5,765 |
| 2026-05-01 | $7,604 |
| 2026-06-01 | $9,216 |
| 2026-07-01 | $10,647 |
| 2026-08-01 | $6,965 |
| 2026-09-01 | $8,176 |
| 2026-10-01 | $8,822 |
Annual Returns
View full annual returns data
| Year | Return |
|---|---|
| 2026 | 40.3% |
Rolling 12-Month Returns
Rolling 12-Month Annualised Volatility
Historical Drawdowns
Monthly Returns
Monthly Returns Heatmap
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Ann. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.8 | -7.5 | 3.4 | -4.9 | 31.9 | 21.2 | 15.5 | -34.6 | 17.4 | 7.9 | — | — | 40.3% |
| 2025 | — | — | — | — | — | — | — | — | — | — | — | -37.1 | -37.1% |
Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.
Factor Risk Decomposition
Share of annualised volatility attributable to each macro factor.
View full factor risk breakdown
| Factor | Risk Exposure |
|---|---|
| VTI.US | -2.0% |
| VEA.US | 7.5% |
| VWO.US | -0.1% |
| QQQ.US | -0.4% |
| VTV.US | 13.1% |
| IJR.US | -2.4% |
| QUAL.US | -1.1% |
| SHV.US | 3.4% |
| TLT.US | 3.3% |
| LQD.US | 8.7% |
| HYG.US | 6.5% |
| GLD.US | 1.1% |
| USO.US | 4.4% |
| VNQ.US | 0.0% |
| BTC-USD.CC | 7.0% |
| CPER.US | -0.7% |
| VIX.INDX | 5.2% |
| UUP.US | 46.2% |
| TIP.US | 0.3% |
| Idiosyncratic | 0.0% |
BillionToOne, Inc. Class A Common Stock Business Fundamentals
Reported valuation multiples, trailing margins, YoY growth, and balance-sheet liquidity.
Valuation Multiples
Grade: FProfitability & Margins
Year-over-Year Growth
Financial Position
Market Sentiment
Dividend & Income Analysisi10-Year historical income simulation on a $10,000 initial investment, cumulative dividend income generated, average yield on cost, and annual payout table.
Based on $10,000 initial investment.
Momentum & MacroiPrice momentum indicators: distance from 50/200-Day SMA, 52-Week High proximity, Golden Cross trend signal, RSI momentum gauge, Fibonacci retracement levels, and Beta (market sensitivity).
In-Depth Analysis
BLLN.US — 10-Year Return & Risk Profile
BillionToOne, Inc. Class A Common Stock (BLLN.US) has delivered negative annualized growth of 12.8% over the last 10 years. A $10,000 investment at the start of the period would have grown to approximately $2,538, representing a total return of 75%. Over this period, BLLN.US generated positive annual returns in 10 out of 10 calendar years (100%).
The best single calendar year for BLLN.US was 2026, with a return of +40.3%. The worst year was 2026, when the asset declined 40.3%. This spread between best and worst year is a useful indicator of the range of outcomes an investor might have experienced in a given 12-month window.
The asset's Sharpe ratio of 0.16 is considered poor on a risk-adjusted basis. The Sharpe ratio measures return earned above the risk-free rate per unit of total volatility — a higher reading indicates more efficient return generation relative to the risk taken. Investors focused on risk-adjusted outcomes should weigh this figure alongside absolute CAGR when making allocation decisions.
BLLN.US — Drawdown, Volatility & Downside Risk
BLLN.US's annualized volatility of 75.3% is classified as high relative to the long-run US equity benchmark of approximately 15%. This above-average volatility means investors in BLLN.US have historically experienced larger day-to-day price swings than the broader market, which requires a higher tolerance for short-term portfolio fluctuations.
The asset's maximum peak-to-trough decline over the study period was 42.3% — a severe bear-market collapse. Drawdown magnitude is a critical consideration for investors who may need to liquidate positions during market stress, as a larger decline requires proportionally greater subsequent gains to recover to the prior peak. A 42% drawdown, for example, requires a 73% gain just to break even.
When evaluating BLLN.US for inclusion in a diversified US portfolio, it is important to note that historical volatility and drawdown metrics are backward-looking. They capture the risk environment of the past 10 years, which included the COVID-19 market crash (2020), the 2022 Federal Reserve rate hike cycle, and various geopolitical disruptions. Future risk may differ materially, particularly in response to structural changes in US monetary policy, sector regulation, or macroeconomic regime shifts.
BLLN.US — Macroeconomic Factor Risk Exposure
The macroeconomic factor model attributes 46.2% of BLLN.US's return variance to US Dollar Strength. This means that when US Dollar Strength rises or falls sharply, BLLN.US tends to move in the same direction with meaningful magnitude. Investors who already hold significant exposure to this factor — through other funds or direct equity positions — should be aware of this concentration when sizing their BLLN.US allocation.
The second-largest macro driver is US Value Equities, contributing 13.1% of variance. 0.0% of BLLN.US's risk is attributable to idiosyncratic, stock-specific factors that are uncorrelated with the broader macro drivers. A higher idiosyncratic share generally indicates that the fund's performance is more dependent on the security selection or holdings composition of the individual underlying assets, rather than broad market forces.
For US investors building a diversified multi-asset portfolio, understanding BLLN.US's factor exposures helps assess its marginal contribution to overall portfolio risk. Adding BLLN.US alongside assets with low correlation to US Dollar Strength — such as US Treasury bonds, commodities, or assets with significant developed-market ex-US exposure — can reduce the overall portfolio's sensitivity to any single macroeconomic theme.
Compare this AssetiRun a head-to-head backtest and risk analysis against similar assets.
Compare BillionToOne, Inc. Class A Common Stock vs BrightSpring Health Services, Inc. Common Stock
Compare BillionToOne, Inc. Class A Common Stock vs argenx NV ADR
Compare BillionToOne, Inc. Class A Common Stock vs Belite Bio Inc ADR
Compare BillionToOne, Inc. Class A Common Stock vs Arrowhead Pharmaceuticals Inc
Compare BillionToOne, Inc. Class A Common Stock vs BioLife Solutions Inc
Compare BillionToOne, Inc. Class A Common Stock vs Astrana Health Inc
Frequently Asked Questions & Methodology
Is BillionToOne, Inc. Class A Common Stock a high-risk investment?
BillionToOne, Inc. Class A Common Stock (BLLN.US) has an annualized volatility of 221.8% and experienced a maximum drawdown of 42.3% over the last 10 years. Its primary macro risk driver is UUP.US.
What is the 10-year return of BLLN.US?
Over the past 10 years, BLLN.US has generated a Compound Annual Growth Rate (CAGR) of -12.8%. A $10,000 investment would have grown to approximately $2,538. It has had a positive return in 100% of calendar years.
What is BLLN.US's Sharpe ratio?
BLLN.US has a Sharpe ratio of 0.16 and a Sortino ratio of 0.20 over the 10-year period. The Sharpe ratio measures risk-adjusted return — how much excess return is earned per unit of volatility. A reading below 1.0 suggests investors were not fully compensated on a risk-adjusted basis.
What is BLLN.US's dividend yield?
BLLN.US does not pay a meaningful dividend. Its returns are driven primarily by price appreciation. Investors seeking regular income may wish to consider dividend-focused alternatives.
Is BLLN.US above its 200-day moving average?
BLLN.US is currently above its 200-day moving average by 19.2%. The current trend signal is: Bullish — 50 SMA above 200 SMA. The 200-day SMA is a widely used long-term trend filter — assets trading above it tend to exhibit positive price momentum.
Data Methodology & Trust
The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.
Run a Full Backtest on BillionToOne, Inc. Class A Common Stock
stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.
Start a Free Backtest